Zoledronic acid inhibits osteoclastogenesis and bone resorptive function by suppressing RANKL‑mediated NF‑κB and JNK and their downstream signalling pathwaysXiaolin Huang, Jian Liao|Molecular Medicine Reports|2021Cited by 28